Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma

Clin Lymphoma Myeloma Leuk. 2016 May;16(5):e59-64. doi: 10.1016/j.clml.2016.02.037. Epub 2016 Feb 27.
No abstract available

Keywords: CD138; CDC; Cytogenetic abnormality; Daratumumab; Monoclonal antibody.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / genetics
  • ADP-ribosyl Cyclase 1 / metabolism*
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Biopsy
  • Bone Marrow / pathology
  • Drug Substitution
  • Fatal Outcome
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • Male
  • Melphalan / therapeutic use
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / metabolism*
  • Prednisone / therapeutic use

Substances

  • Biomarkers
  • ADP-ribosyl Cyclase 1
  • Melphalan
  • Prednisone

Supplementary concepts

  • AP protocol 2